ALKBH5 modulates bone cancer pain in a rat model by suppressing NR2B expression
Sign Up to like & getrecommendations! Published in 2024 at "Biotechnology and Applied Biochemistry"
DOI: 10.1002/bab.2601
Abstract: Currently, the clinical treatment of bone cancer pain (BCP) is mainly related to its pathogenesis. The aim of the present study was to elucidate the potential role of N6‐methyladenosine (m6A) in BCP in the spinal… read more here.
Keywords: bone cancer; alkbh5; rat model; expression ... See more keywords